Small minds, big oppression
By Jenny Thompson on 02/17/2011
Okay…who woke up the FDA?
Suddenly these good little bureaucrats are powering up their hive-mind in order to “protect” us from safe, non-drug treatments.
Recently I told you about new FDA actions that will severely limit access to intravenous ascorbic acid (IAA), a proven cancer-fighter that has been shown to neutralize virtually any pathogenic organism.
Apparently the FDA has decided that IAA is an unapproved drug. And because it’s obviously NOT a drug and can’t be patented, they’ve basically found a way to make therapeutic doses of vitamin C illegal.
When it comes to being small-minded and petty, these FDA drones are extremely effective.
But IAA isn’t the only item on their hit list. Now they’re zeroing in on niacin. Which just HAPPENS to be a direct competitor of Big Pharma’s cash cow: statin drugs.
You can’t say that
Last month, FDA officials told Upsher Smith, a small Minnesota pharmaceutical company, that they couldn’t reference niacin studies in their marketing of SLO-NIACIN–a supplement with sustained-release to reduce the warm, tingling effect that niacin sometimes causes.
So it’s basically just niacin.
Upsher Smith has temporarily taken the SLO-NIACIN info off their website. But the FDA warning letter lists several studies that pose a problem. One study, published in the American Journal of Cardiology in 1992 is titled, “Marked benefit with sustained-release niacin therapy in patients with ‘isolated’ very low levels of high-density lipoprotein cholesterol and coronary artery disease.”
Now, just think about that. There’s a study in a major medical journal that shows a “marked benefit” in artery disease patients who take sustained-release niacin.
But the FDA doesn’t want you to read about that on the Upsher Smith site. (Or maybe they don’t want you to read about it at all…)
But either way, does the suppression of this information serve artery disease patients?
Other studies (which may or may not have been on the site) show that niacin also helps reduce triglycerides, and may help prevent dementia, arthritis, and anxiety.
When Dr. Spreen sent me an article about this new FDA action, he noted that niacin is also listed in the Physicians’ Desk Reference as a therapeutic agent to lower cholesterol. It’s right there in the medical mainstream’s public record–the source ALL doctors turn to when treating patients.
But if you make and sell niacin, you can’t mention this PROVEN benefit to your prospective customers?
Something is really WRONG with this picture!
Years ago, suffragette Crystal Eastman said, “Tyranny goes by the name of protection.”
I can’t imagine how much stronger a statement she would make today if she saw the workings of the FDA…especially if she were faced with heart disease.